Clinical Trial

Long-term Safety and Tolerability of BHV-7000

Name: Long-term Safety and Tolerability of BHV-7000 — clinical trial record (NCT06443463)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Enrolling by Invitation Phase 2

View on ClinicalTrials.gov →

Summary

A study to determine if BHV- 7000 is safe and tolerable in adults with refractory focal onset epilepsy

Protocol Amendment History 41 amendments

This ClinicalTrials.gov record has been amended 41 times since 2024-05-30; most recent amendment 2026-04-30.

Status change: Not Yet Recruiting → Enrolling by Invitation 2024-07-16

Trial Details

NCT Number	NCT06443463
Lead Sponsor	Biohaven Therapeutics Ltd.
Conditions	Focal Epilepsy
Enrollment	660 participants
Start Date	2024-07-30
Primary Completion	2026-12 (estimated)
Study Completion	2027-01 (estimated)
Updated on ClinicalTrials.gov	2026-05-01